Who Owns Lumen Technologies (CH:CYTH)? According to the latest TipRanks data, approximately 45.75% of the company's stock is held by institutional investors, 2.49% is held by insiders, and 51.76% is ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Responsible for the fan fiction that inspired the Rem/Steve Rogers picture…yes that one.
Oct. 29 Rafael Holdings Inc And Cyclo Therapeutics LLC Submit New Drug Application To FDA For Trappsol Cyclo Remibetadex For Treatment Of Niemann-Pick Disease Type C CI Apr. 22 Cyclo Therapeutics ...
Lumen delivered Q1 2026 results in line with expectations, with total business revenue down 3.2% YoY to $2.44B and adjusted EBITDA of $849M, above consensus. Management raised 2026 free cash flow ...
Lumen Technologies is one of the largest telecommunications carriers serving global enterprises. The merger with Level 3 in 2017, the 2022 divestiture of much of its local phone business in rural ...
A clinical-stage biotech compan developing cyclodextrin-based products for the treatment of neurodegenerative diseases. In August 2024, Rafael Holdings (NYSE: RFL) and Cyclo Therapeutics (Nasdaq: CYTH ...
The consensus is easy to state, and its strongest version is genuinely right: LightPath Technologies LPTH--makes the infrared optics and optical assemblies that go into drones, missiles, and ...
Office DOOH is not standard DOOH: Lumen study finds ECN screens earn 3.4x more attention than comparable digital out-of-home ECN office screens deliver 1.25x the attention of large-format roadside and ...